Current and novel therapies for management of Acinetobacter baumannii-associated pneumonia
AMS Shein, P Hongsing, ORK Smith… - Critical Reviews in …, 2024 - Taylor & Francis
Acinetobacter baumannii is a common pathogen associated with hospital-acquired
pneumonia showing increased resistance to carbapenem and colistin antibiotics nowadays …
pneumonia showing increased resistance to carbapenem and colistin antibiotics nowadays …
[HTML][HTML] Novel intranasal phage-CaEDTA-ceftazidime/avibactam triple combination therapy demonstrates remarkable efficacy in treating Pseudomonas aeruginosa …
Given the rise of multidrug-resistant (MDR) Pseudomonas aeruginosa infections, alternative
treatments are needed. Anti-pseudomonal phage therapy shows promise, but its clinical …
treatments are needed. Anti-pseudomonal phage therapy shows promise, but its clinical …